Piramal Pharma Limited (NSE:PPLPHARMA)

Piramal Pharma Revenue

Piramal Pharma had revenue of 22.70B INR in the quarter ending June 30, 2026, with 17.39% growth. This brings the company's revenue in the last twelve months to 92.05B, up 0.78% year-over-year. In the fiscal year ending March 31, 2026, Piramal Pharma had annual revenue of 88.69B, down -3.08%.

• Revenue (ttm): 92.05B
• Revenue Growth: +0.78%
• P/S Ratio: 2.82
• Revenue / Employee: 12.93M
• Employees: 7,120
• Market Cap: 259.61B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	88.69B	-2.82B	-3.08%
Mar 31, 2025	91.51B	9.80B	11.99%
Mar 31, 2024	81.71B	10.90B	15.39%
Mar 31, 2023	70.82B	3.47B	5.16%
Mar 31, 2022	67.34B	8.47B	14.39%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 1, 2026

Data Sources Report a data error